Physician

Hematology

Bruce Porterfield is an expert in the field of Hematology. He went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He received 1 awards: "Meaningful Use Stage 1 Certification". Bruce W. Porterfield has written publications. He has 5 publications published with PubMed. The lastest paper is: 'Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids.' Doctor Bruce W. Porterfield, MD is registered with Medicare and accepts Medicare payments.

Publications

---

• Chemoprevention of prostate Cancer with selenium: an update on current clinical trials and preclinical findings.
• Selenium and prostate Cancer prevention.
• Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids.
• The use of methylthioadenosine phosphorylase activity to select for human chromosome 9 in interspecies and intraspecies hybrid cells.

Schools

---

• University of Chicago

• University Of Az College Of Med

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology
• Hematology

Accepted Insurances

---

Awards

---

• Meaningful Use Stage 1 Certification

Education

---

• University of Arizona
• University of Chicago Pritzker School of Medicine

Drug Facts

---

NPI NUMBER		1962451377
NPPES Provider LastName		PORTERFIELD
NPPES Provider FirstName		BRUCE
NPPES Provider ZIPCode		856141915
NPPES Provider State		AZ
Specialty Description		Hematology/Oncology
Total Claim Count		1860.0
Distinct Opioid Count		7.0
Opioid Claim Count		219.0
Percent Opioid Claims		11.77

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1962451377
Last Name Of The Provider	PORTERFIELD
First Name Of The Provider	BRUCE
View All

---

Doctor Directory | TOS | twitter | FB | Angel | blog